The serotonin axis in cancer: metabolism, epigenetics, and immune regulation
Molecular Cancer · Published 2026-08-03 · DOI 10.1186/s12943-026-02764-w
Free full text
Authors (4)
Jiazhuang Zhu, Junping Bai, Liwei An, Chunlin Zhang
Abstract
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Publication details
- Year
- 2026
Citation
Zhu, J., Bai, J., An, L., et al. (2026). The serotonin axis in cancer: metabolism, epigenetics, and immune regulation. Molecular Cancer. https://doi.org/10.1186/s12943-026-02764-w
Related articles
- AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemia · Molecular Cancer · 2026 · Same journal
- Breaking the immune “cold niche” in bone metastasis: core mechanisms of the multidimensional interwoven regulatory network and precision breakthrough strategies · Molecular Cancer · 2026 · Same journal
- Redifferentiation-enabled TSHRCART cells overcome antigen loss in aggressive thyroid cancers · Molecular Cancer · 2026 · Same journal
- Landscape of T-cell bispecific antibodies in cancer therapy: therapeutic strategies, challenges and future prospection · Molecular Cancer · 2026 · Same journal
- Trace elements and tumors: homeostatic networks, molecular mechanisms and new horizons for precision intervention · Molecular Cancer · 2026 · Same journal
- Autophagy in cancer — functional plasticity, therapeutic paradox, and the road to precision modulation: a comprehensive review · Molecular Cancer · 2026 · Same journal
- Multimodal sequencing identifies synergistic mechanisms driving resistance to neoadjuvant nivolumab treatment in hepatocellular carcinoma · Molecular Cancer · 2026 · Same journal
- Reprogramming the pancreatic ductal adenocarcinoma microenvironment: a novel integrin-targeted cytotoxin, ProAgio, potentiates chemotherapy · Molecular Cancer · 2026 · Same journal
- ADSL drives fumarate mediated scrib-rictor complex formation to promote metastasis dissemination in triple-negative breast cancer · Molecular Cancer · 2026 · Same journal
- Liposomal drug delivery for lung cancer therapy: progress, challenges, and future perspectives · Molecular Cancer · 2026 · Same journal